Novartis AG (NVS) , a Swiss pharma giant, is scheduled to report first-quarter 2024 results on Apr 23. The company’s earnings surpassed estimates in three of the last four quarters and missed in the remaining one, the average surprise being 3.72%. In the last reported quarter, NVS’ earnings missed estimates by 6.71%. Let's see how things might have shaped up prior to the announcement. Factors Driving Growth With the successful spin-off of the Sandoz business in October 2023, Novartis operates as a single gl ...